Switching from Prozac to Luvox

Recommended Switching Protocol

• When switching from fluoxetine to fluvoxamine, a conservative cross-tapering approach is recommended, reducing fluoxetine by 25% weekly while starting fluvoxamine at a low dose (25-50 mg daily) after 1-2 weeks, given fluoxetine's exceptionally long half-life compared to fluvoxamine's short half-life, as suggested by Praxis Medical Insights 1
• The American College of Clinical Pharmacology recommends reducing fluoxetine dose by 25-50% of the original dose, and starting fluvoxamine at 25-50 mg daily while continuing reduced fluoxetine dose, to minimize the risk of serotonin syndrome 1
• The typical therapeutic dose range for fluvoxamine is 100-150 mg daily for depression, and it can be gradually increased to this range in divided doses, as recommended by Praxis Medical Insights 1

Critical Drug Interaction Considerations

• Fluvoxamine has significantly greater potential for drug-drug interactions than fluoxetine due to its inhibition of multiple CYP450 enzymes, and a review of all concomitant medications for potential interactions is necessary before initiating the switch, as suggested by Praxis Medical Insights 1

Monitoring During the Switch

• Close monitoring for serotonin syndrome is necessary during the overlap period, particularly in the first 24-48 hours after each dose change, as recommended by Praxis Medical Insights 1
• Follow-up within 1-2 weeks after completing the switch is necessary to assess therapeutic response and adverse effects, as suggested by Praxis Medical Insights 1
• Continued monitoring for 4-6 weeks is recommended to ensure stabilization on fluvoxamine, as full therapeutic effects may take this long, according to Praxis Medical Insights 1
• The antidepressant efficacy of fluvoxamine is equivalent to that of fluoxetine, as reported by the Annals of Internal Medicine 2